- Home
- VCIG vs HOTH Comparison
VCIG vs HOTH Comparison
Compare VCIG & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- HOTH
- Stock Information
- Founded
- VCIG 2013
- HOTH 2017
- Country
- VCIG Malaysia
- HOTH United States
- Employees
- VCIG N/A
- HOTH N/A
- Industry
- VCIG Diversified Commercial Services
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- VCIG Consumer Discretionary
- HOTH Health Care
- Exchange
- VCIG Nasdaq
- HOTH Nasdaq
- Market Cap
- VCIG 10.2M
- HOTH 8.3M
- IPO Year
- VCIG 2023
- HOTH 2019
- Fundamental
- Price
- VCIG $1.71
- HOTH $1.18
- Analyst Decision
- VCIG
- HOTH Strong Buy
- Analyst Count
- VCIG 0
- HOTH 3
- Target Price
- VCIG N/A
- HOTH $4.00
- AVG Volume (30 Days)
- VCIG 1.3M
- HOTH 1.4M
- Earning Date
- VCIG 08-18-2025
- HOTH 05-12-2025
- Dividend Yield
- VCIG N/A
- HOTH N/A
- EPS Growth
- VCIG N/A
- HOTH N/A
- EPS
- VCIG 54.73
- HOTH N/A
- Revenue
- VCIG $27,819,290.00
- HOTH N/A
- Revenue This Year
- VCIG N/A
- HOTH N/A
- Revenue Next Year
- VCIG N/A
- HOTH N/A
- P/E Ratio
- VCIG $0.03
- HOTH N/A
- Revenue Growth
- VCIG 36.99
- HOTH N/A
- 52 Week Low
- VCIG $1.67
- HOTH $0.58
- 52 Week High
- VCIG $588.00
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- VCIG 32.39
- HOTH 53.20
- Support Level
- VCIG $1.67
- HOTH $1.15
- Resistance Level
- VCIG $2.45
- HOTH $1.34
- Average True Range (ATR)
- VCIG 0.28
- HOTH 0.10
- MACD
- VCIG -0.01
- HOTH -0.02
- Stochastic Oscillator
- VCIG 6.03
- HOTH 32.35
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.